Our results seem to indicate that intramuscular triglyceride content in VL does not determine the development of systemic insulin resistance, nor should it be used as a marker of decreased insulin sensitivity in obesity, as previously suggested [32]. The gene discussed is INS; the disease is obesity disorder.